A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer

NCT01281514 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Fallopian Tube Cancer
Peritoneal Cavity Cancer
Recurrent Ovarian Epithelial Cancer

Interventions

DRUG: everolimus
DRUG: carboplatin
DRUG: pegylated liposomal doxorubicin hydrochloride
OTHER: laboratory biomarker analysis

Sponsor

Fox Chase Cancer Center